Yang YI et al. have reported that tectorigenin increased the paclitaxel sensitivity of paclitaxel-resistant human ovarian cancer cells through the downregulation of the AKT and NF-κB signaling pathways [29]. The gene discussed is AKT1; the disease is ovarian cancer.